738
Participants
Start Date
August 31, 2016
Primary Completion Date
January 31, 2018
Study Completion Date
January 31, 2018
lefamulin
antibacterial agent
Moxifloxacin
antibacterial agent
Site 4253, Tbilisi
Site 4255, Tbilisi
Site 4252, Tbilisi
Site 4254, Tbilisi
Site 5152, Queenswood
Site 5153, Witbank
Site 5155, Middelburg
Site 2056, Quezon City
Site 2054, Quezon
Site 4354, Budapest
Site 5263, Kyiv
Site 4353, Budapest
Site 4160, Sofia
Site 4157, Sofia
Site 2053, Caloocan City
Site 4153, Sofia
Site 4156, Sofia
Site 4161, Sofia
Site 5154, Krugersdorp
Site 5055, Knez-Selo
Site 4955, Saint Petersburg
Site 4351, Törökbálint
SIte 5252, Kyiv
Site 2251, Seoul
Site 4152, Vratsa
Site 4554, Alicante
Site 4352, Mátraháza
Site 5259, Poltava
Site 5251, Kyiv
Site 5265, Kyiv
Site 4159, Vidin
Site 2052, Iloilo City
Site 4158, Stara Zagora
Site 2055, Cebu
Site 4954, Novosibirsk
4162, Rousse
Site 5258, Ivano-Frankivsk
Site 2252, Seoul
Site 4552, Barcelona
Site 4555, Barcelona
Site 4154, Sliven
Site 4556, Badalona
Site 5151, Bloemfontein
Site 5052, Belgrade
Site 5056, Belgrade
Site 5051, Belgrade
Site 2254, Uijeongbu-si
Site 2257, Bucheon-si
Site 1153, Aguascalientes
Site 5260, Vinnytsia
Site 4855, Bucharest
Site 5053, Kamenitz
Site 4858, Bucharest
Site 1059, Charlottesville
Site 4553, Madrid
Site 4551, Madrid
Site 4854, Bucharest
Site 1064, DeBary
Site 1052, DeLand
Site 5054, Kragujevac
Site 2253, Daegu
Site 1154, Guadalajara
Site 1067, Lima
Site 1051, Michigan City
Site 1068, Royal Oak
Site 1055, Detroit
Site 1062, Detroit
Site 1152, Toluca
Site 1056, Rapid City
Site 5264, Chernivtsi
Site 1054, Butte
Site 5256, Kharkiv
Site 5254, Kharkiv
Site 1058, St Louis
Site 1151, Monterrey
Site 5253, Zaporizhzhya
Site 5257, Zaporizhzhya
Site 1057, Natchitoches
Site 5255, Kherson
Site 5261, Ivano-Frankivsk
Site 1060, Houston
Site 1069, Houston
Site 1066, Splendora
Site 2352, Kaohsiung City
Site 1053, Sylmar
Site 1072, Oxnard
Site 1065, Fresno
Site 1070, Sacramento
Site 4957, Moscow
Site 4952, Moscow
Site 4951, Saint Petersburg
Site 4857, Craiova
Site 4958, Smolensk
Site 4856, Timișoara
Site 4853, Cluj-Napoca
Site 4959, Saratov
Site 4851, Codlea
Site 4953, Barnaul
1080, Beverly Hills
1078, Northridge
1079, Sherman Oaks
1076, Miami
1077, Hendersonville
Site 3056, Buenos Aires
Site 3059, Buenos Aires AV
Site 3052, Córdoba
Site 3057, Córdoba
Site 3058, General Pacheco
Site 3051, La Plata
Site 3053, La Plata
4163, Sofia
4164, Sofia
4165, Sofia
Site 3353, Santiago
Site 3356, Santiago
Site 3357, Santiago
Site 3354, Talca
Site 3352, Temuco
Site 3355, Valdivia
Site 4256, Batumi
Site 3264, Grau
Site 3262, Arequipa
Site 3263, Cusco
Site 3261, Cuzco
Site 3254, Ica
Site 3259, Iquitos
Site 3251, La Libertad
Site 3252, Lima
Site 3253, Lima
Site 3255, Lima
Site 3257, Lima
Site 3260, Lima
Site 3265, Lima
Site 3258, Lima Lima
Site 3256, Piura
Site 2051, Quezon City
5057, Belgrade
Site 5156, Pretoria
Site 2351, Kaohsiung City
Site 2354, Taipei
Site 1073, New Bedford
Site 3054, Córdoba
Site 3154, Belo Horizonte
Site 3153, Passo Fundo
Site 3152, São José do Rio Preto
Site 4451, Liepāja
Site 4453, Riga
Site 4452, Valmiera
Site 4755, Bochnia
Site 4754, Chodzież
Site 4753, Krakow
Site 4756, Krakow
Site 4757, Siedlce
Site 2255, Seoul
Site 2256, Seoul
Lead Sponsor
Nabriva Therapeutics AG
INDUSTRY